Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Aug;74(3):491–493. doi: 10.1038/bjc.1996.389

Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China.

J M Yuan 1, S Govindarajan 1, B E Henderson 1, M C Yu 1
PMCID: PMC2074655  PMID: 8695372

Abstract

Southern Guangxi, China has one of the highest incidences of hepatocellular carcinoma (HCC) in the world. Serum samples collected from subjects of an earlier case-control study (39 cases, 41 controls) and from a random sampling of a residential male cohort (n = 100) were tested for antibodies for the hepatitis C virus (anti-HCV) using ELISA version 2.0 with confirmation by RIBA version 2.0. Only one of 141 (0.7%, upper 95% confidence limit, 3.2%) control subjects and none of 39 (upper 95% confidence limit, 6.07%) HCC cases tested positive for anti-HCV. Our results indicate that hepatitis C infection is not an important environmental determinant of HCC risk in this hyperendemic region.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang C. C., Yu M. W., Lu C. F., Yang C. S., Chen C. J. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol. 1994 Jul;43(3):276–280. doi: 10.1002/jmv.1890430315. [DOI] [PubMed] [Google Scholar]
  2. Chuang W. L., Chang W. Y., Lu S. N., Su W. P., Lin Z. Y., Chen S. C., Hsieh M. Y., Wang L. Y., You S. L., Chen C. J. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer. 1992 Apr 15;69(8):2052–2054. doi: 10.1002/1097-0142(19920415)69:8<2052::aid-cncr2820690808>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  3. Hamasaki K., Nakata K., Tsutsumi T., Tsuruta S., Nakao K., Kato Y., Shima M., Koji T., Nagataki S. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol. 1993 Jun;40(2):146–149. doi: 10.1002/jmv.1890400212. [DOI] [PubMed] [Google Scholar]
  4. Ito S., Yao D. F., Nii C., Hibino S., Kamamura M., Nisikado T., Honda H., Shimizu I., Meng X. Y. Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol. 1993 May-Jun;8(3):232–237. doi: 10.1111/j.1440-1746.1993.tb01192.x. [DOI] [PubMed] [Google Scholar]
  5. Jeng J. E., Tsai J. F. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol. 1991 May;34(1):74–77. doi: 10.1002/jmv.1890340113. [DOI] [PubMed] [Google Scholar]
  6. Lee S. D., Lee F. Y., Wu J. C., Hwang S. J., Wang S. S., Lo K. J. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer. 1992 Jan 15;69(2):342–345. doi: 10.1002/1097-0142(19920115)69:2<342::aid-cncr2820690211>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  7. Leung N. W., Tam J. S., Lai J. Y., Leung T. W., Lau W. Y., Shiu W., Li A. K. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer. 1992 Jul 1;70(1):40–44. doi: 10.1002/1097-0142(19920701)70:1<40::aid-cncr2820700107>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  8. Nakashima K., Kashiwagi S., Hayashi J., Noguchi A., Hirata M., Kajiyama W., Urabe K., Minami K., Maeda Y. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol. 1992 Nov 1;136(9):1132–1137. doi: 10.1093/oxfordjournals.aje.a116579. [DOI] [PubMed] [Google Scholar]
  9. Okuno H., Xie Z. C., Lu B. Y., Qin X., Takasu M., Kano H., Shiozaki Y., Inoue K. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China. Cancer. 1994 Jan 1;73(1):58–62. doi: 10.1002/1097-0142(19940101)73:1<58::aid-cncr2820730112>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  10. Qian G. S., Ross R. K., Yu M. C., Yuan J. M., Gao Y. T., Henderson B. E., Wogan G. N., Groopman J. D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):3–10. [PubMed] [Google Scholar]
  11. Ross R. K., Yuan J. M., Yu M. C., Wogan G. N., Qian G. S., Tu J. T., Groopman J. D., Gao Y. T., Henderson B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 1992 Apr 18;339(8799):943–946. doi: 10.1016/0140-6736(92)91528-g. [DOI] [PubMed] [Google Scholar]
  12. Suga M., Senota A., Arima K., Kodama T., Ikuta S., Sakamoto H., Ohe Y., Sugai S., Yachi A. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma. Hepatogastroenterology. 1994 Oct;41(5):438–441. [PubMed] [Google Scholar]
  13. Tanaka H., Hiyama T., Tsukuma H., Okubo Y., Yamano H., Kitada A., Fujimoto I. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control. 1994 Sep;5(5):409–413. doi: 10.1007/BF01694754. [DOI] [PubMed] [Google Scholar]
  14. Tanaka K., Hirohata T., Koga S., Sugimachi K., Kanematsu T., Ohryohji F., Nawata H., Ishibashi H., Maeda Y., Kiyokawa H. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 1991 Jun 1;51(11):2842–2847. [PubMed] [Google Scholar]
  15. Tomimatsu M., Ishiguro N., Taniai M., Okuda H., Saito A., Obata H., Yamamoto M., Takasaki K., Nakano M. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer. 1993 Aug 1;72(3):683–688. doi: 10.1002/1097-0142(19930801)72:3<683::aid-cncr2820720310>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  16. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol. 1994 Sep;44(1):92–95. doi: 10.1002/jmv.1890440117. [DOI] [PubMed] [Google Scholar]
  17. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver. 1994 Apr;14(2):98–102. doi: 10.1111/j.1600-0676.1994.tb00055.x. [DOI] [PubMed] [Google Scholar]
  18. Tsai J. F., Jeng J. E., Ho M. S., Chang W. Y., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer. 1994 Mar 1;56(5):619–621. doi: 10.1002/ijc.2910560502. [DOI] [PubMed] [Google Scholar]
  19. White C. Two Cases of Puerperal Anuria in which the Renal Capsule was incised and Portions of the Kidney Substance removed for Examination. Proc R Soc Med. 1919;12(OBSTET):27–31. doi: 10.1177/003591571901200906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ye B., Shen J., Xu Y. [Etiologic study on the relationship between HBV, HCV and HCC]. Zhonghua Liu Xing Bing Xue Za Zhi. 1994 Jun;15(3):131–134. [PubMed] [Google Scholar]
  21. Yeh F. S., Mo C. C., Luo S., Henderson B. E., Tong M. J., Yu M. C. A serological case-control study of primary hepatocellular carcinoma in Guangxi, China. Cancer Res. 1985 Feb;45(2):872–873. [PubMed] [Google Scholar]
  22. Yeh F. S., Yu M. C., Mo C. C., Luo S., Tong M. J., Henderson B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 1989 May 1;49(9):2506–2509. [PubMed] [Google Scholar]
  23. Yu M. C., Tong M. J., Coursaget P., Ross R. K., Govindarajan S., Henderson B. E. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst. 1990 Jun 20;82(12):1038–1041. doi: 10.1093/jnci/82.12.1038. [DOI] [PubMed] [Google Scholar]
  24. Yuan J. M., Ross R. K., Stanczyk F. Z., Govindarajan S., Gao Y. T., Henderson B. E., Yu M. C. A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer. 1995 Nov 15;63(4):491–493. doi: 10.1002/ijc.2910630405. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES